Table 4.
Parameter | No Evidence of New/Enlarged ICH (n = 54) | Evidence of New/Enlarged ICH (n = 27) | p-value |
---|---|---|---|
EVD placed by a trainee or mid-level practitioner, n (%) a | 19 (35.19) | 8 (29.63%) | 0.6171 |
Placement Attempts, (Median ± IQR) (n = 69) b | 1 (0) | 1 (0) | 0.8831 |
Anticoagulation within 96 h of EVD, n (%) a | 14 (25.9) | 2 (7.4) | 0.048 |
Prophylactic anticoagulation, n (%) a, d | 11 (20.4) | 2 (7.4) | > 0.999 |
Antiplatelet within 96 h of EVD, n (%) c | 3 (5.6) | 6 (22.2) | 0.0539 |
GCS (lowest) POD 1, (Median ± IQR) b | 6 ± 6 | 6 ± 6 | 0.17 |
GCS (lowest) POD 2, (Median ± IQR) (n = 80) b | 6.5 ± 7.8 | 4.5 ± 6.5 | 0.0624 |
GCS (lowest) POD 3, (Median ± IQR) (n = 76) b | 8 ± 10 | 3 ± 6.8 | 0.0202 |
GCS (lowest) POD 4, (Median ± IQR) (n = 72) b | 9 ± 10 | 4 ± 5.3 | 0.0383 |
aChi Square
bMann-Whitney U
cFisher’s Exact
dInferential test was performed on in those patients who received anticoagulation